BREAST CANCER
Gabriel N. Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Promoted the use of chemotherapy prior to surgery
Acceptance Speech
- Gabriel N. Hortobagyi, MD, is a professor of medicine in the Department of
Breast Medical Oncology and the Nellie B. Connally Chair in Breast Cancer
at The University of Texas MD Anderson Cancer Center. He also is program
director of the Susan G. Komen Interdisciplinary Breast Fellowship Program
at MD Anderson. His work and accomplishments include:
- Developed and promoted the use of presurgical chemotherapy in patients with large tumors, reducing the tumors to 50% of their size prior to surgery and enabling subsequent surgical removal
- Involved in the drug development of anthracyclines and taxanes in breast cancer therapy
- Established the role of bisphosphonates in the management of bone metastases from breast cancer
- Developed gene therapy approaches to breast cancer, and played a role in the initial development of gene expression profiling and its prognostic and predictive application in breast cancers
- Past president of the American Society of Clinical Oncology
- Chair of the Southwest Oncology Group since 2007
- Recipient of numerous awards, including the 2012 William L. McGuire Award and Memorial Lecture, CTCR-AACR San Antonio Breast Cancer Symposium, and the 1997 Brinker International Award for Clinical Research
